Ocimum Biosolutions’ Biotracker™ Software Application Achieves GeneChip-compatible™ Status with Affymetrix’ GeneChip Microarray Platform
Ocimum Biosolutions today announced that its Biotracker™ software application has achieved GeneChip-compatible™ status with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has agreed to participate in the Affymetrix GeneChip-compatible™ Applications Program, which provides customers with a broad spectrum of software solutions for biomedical research and development. As a GeneChip-compatible software provider, Ocimum is committed to seamlessly integrating its Biotracker™ with the Affymetrix GeneChip platform.
Ocimum’s Biotracker™ is a GLP and US FDA 21 CFR Part 11 compliant Laboratory Information and Knowledge Management System. It is an effective tool for improving laboratory performance which allows analysts to keep track of samples, reagents, instruments, processes, and results at every stage of a project. Biotracker™ is a customized LIMS solution which has various modules, some of which are: Laboratory Administration module, Resource Schedule module, Project Tracking, Analysis and Result Archival module, Inventory Management and Tracking System module, Sample Tracking module & Plate tracking module.
“We are very happy to be part of the GeneChip-compatible™ Applications Program with the market leader in the microarray space. Biotracker™ is a very flexible and configurable program and we understand the Affymetrix platform well to provide users with customized solutions,” said Ms. Anuradha Acharya, C.E.O., Ocimum Biosolutions. “Many of our customers are now applying microarray methods initially developed for basic research into translational medicine and clinical research,” said Steve Lincoln, vice president of Informatics at Affymetrix. “We are pleased to be engaged with leading software providers, including Ocimum Biosolutions, in developing integrated solutions to address these emerging needs.”
About Ocimum Biosolutions:
Ocimum Biosolutions is a life sciences R&D enabling company with three focus areas, BioIT, Microarrays and contract research services. The Microarray division of Ocimum has been recently acquired from MWG Biotech. These include Catalog OciChips™, Custom OciChips™ and Hybridization services.
The BioIT division of Ocimum Biosolutions provides key, ready to use reliable, cost-effective software solutions for the biotech/pharma industry with a suite of LIMS and Bioinformatics products such as Biotracker™, Toxchek™, Pharmatracker™, Genchek™, OptGene™, Nutrabase™, Genowiz™ and iRNAchek™. Ocimum also offers custom software solutions for genomics and molecular biology besides doing data analysis as a service.
The Contract services division provides molecular biology services like GMO testing, DNA extractions, fermentation and gene synthesis. For more information about Ocimum, please visit the company’s website at www.ocimumbio.com .
About the Affymetrix Developers Network (ADN):
Through one of the largest third-party software developer communities within the life science industry, Affymetrix works with ADN participants to provide a broad spectrum of solutions for leveraging gene expression and genetic variation analysis in both biomedical research and development. Membership in ADN is free of charge for both commercial and academic software developers. For more information on the ADN Program please visit www.affymetrix.com/genechip/developer . Visit the GeneChip-compatible™ Software Solutions Catalog at www.affymetrix.com/genechip/compatible .
Affymetrix scientists invented the world’s first microarray in 1989 and began selling the first commercial microarray in 1994. Since then, Affymetrix GeneChip® technology has become the industry standard in molecular biology research. Affymetrix GeneChip technology is used by the world’s top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. More than 1,200 systems have been shipped around the world and more than 3,000 peer-reviewed papers have been published using the technology. Affymetrix’ patented photolithographic manufacturing process provides the most information capacity available today on a microarray, enabling researchers to use a whole-genome approach to analyze the relationship between genetics and health. Headquartered in Santa Clara, Calif., Affymetrix has subsidiaries in Europe and Asia in addition to manufacturing facilities in Sacramento, Calif. and Bedford, Mass. The company has about 900 employees worldwide. For more information about Affymetrix, please visit the company’s website at www.affymetrix.com .
